GL1X · GenesisL1 explorer

Research workbench

Structure and function of the hypertension variant A486V of G protein- coupled receptor kinase 4 (GRK4)

Analyse Structure and function of the hypertension variant A486V of G protein- coupled… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4YHJ
Type
protein
Length
991 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
G protein-coupled receptor kinase 4
EC
2.7.11.16
UniProt
P32298
Ligands
AN2
Pockets
16 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AG protein-coupled receptor kinase 4 (EC 2.7.11.16)protein50144% helix, 11% strandP32298
BG protein-coupled receptor kinase 4 (EC 2.7.11.16)protein49048% helix, 11% strandP32298

Ligands and binding sites

  • AN2 · Amp phosphoramidate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18830.790.8272empty
21940.790.9428empty
36470.760.8277AN2
43830.710.8342empty
54130.710.8250AN2

Interfaces

1 interface between chains.

  • A–B · 2264 Ų buried · 41 hydrogen bonds · protein-protein

Compared structures

  • 4YHJ · Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P32298 · AlphaFold monomer V2.0 prediction for G protein-coupled receptor kinase 4 (P32298) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.